These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5626248)

  • 1. [Steatosis of the liver. Biopsy cases].
    Petersen P
    Ugeskr Laeger; 1967 Aug; 129(31):988-90. PubMed ID: 5626248
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the clinical picture of fatty degeneration of the liver and fatty liver].
    Teichmann W; Lindemann A
    Z Gesamte Inn Med; 1967 Sep; 22(17):509-14. PubMed ID: 5591413
    [No Abstract]   [Full Text] [Related]  

  • 3. [When should liver biopsy be considered? Slightly increased ALAT can indicate steatosis--but a histological test is necessary for prognosis].
    Danielsson A
    Lakartidningen; 2004 Sep; 101(38):2862. PubMed ID: 15485168
    [No Abstract]   [Full Text] [Related]  

  • 4. [Liver function tests in tuberculous diabetics].
    Marton S; Kálnai E; Fonyódi T; Hevér O
    Beitr Klin Erforsch Tuberk Lungenkr; 1965 Dec; 131(5):351-7. PubMed ID: 5886209
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of fatty liver with essential phospholipids].
    Arendt R; Nowotny P; Teichmann W
    Z Gesamte Inn Med; 1970 Jul; 25(13):587-9. PubMed ID: 5523267
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the accuracy of laboratory tests in the diagnosis of fatty liver].
    Kaffarnik H; Gross W; Juchems R
    Munch Med Wochenschr; 1967 Jan; 109(4):199-200. PubMed ID: 6071799
    [No Abstract]   [Full Text] [Related]  

  • 7. [Etiopathogenesis and prognosis of fatty liver].
    Margit H; György N; Zoltán K; Gábor P
    Orv Hetil; 1975 Mar; 116(9):494-6. PubMed ID: 1114009
    [No Abstract]   [Full Text] [Related]  

  • 8. [Non-alcoholic fatty liver].
    Zwimpfer J
    Praxis (Bern 1994); 2000 Oct; 89(43):1757-8. PubMed ID: 11103621
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis of fatty liver].
    Thaler H
    Dtsch Med Wochenschr; 1966 Dec; 91(48):2171-2. PubMed ID: 5923858
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quantitative relations between sero-chemical findings, fatty degeneration of the liver, alcohol drinking and body weight in a diabetic and non-diabetic collective with fatty degeneration of the liver].
    Fuchs T; Immich H; Nedden R
    Med Welt; 1971 Mar; 10():392-9. PubMed ID: 5549139
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients.
    Daniel S; Ben-Menachem T; Vasudevan G; Ma CK; Blumenkehl M
    Am J Gastroenterol; 1999 Oct; 94(10):3010-4. PubMed ID: 10520861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of steatosis in alcoholic determined by repeated puncture biopsy of the liver; facts and arguments on deficiency pathogenetic concept of steatosis].
    MENGHINI G; ORLANDI F; BENDA N
    Minerva Med; 1957 Jan; 48(3-4):50-6. PubMed ID: 13418446
    [No Abstract]   [Full Text] [Related]  

  • 13. Body mass index as a predictor of hepatic steatosis in living liver donors.
    Rinella ME; Alonso E; Rao S; Whitington P; Fryer J; Abecassis M; Superina R; Flamm SL; Blei AT
    Liver Transpl; 2001 May; 7(5):409-14. PubMed ID: 11349260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems with NASH? HAIR is some help.
    Phillips H; Balart LA
    Am J Gastroenterol; 2003 Feb; 98(2):500. PubMed ID: 12591077
    [No Abstract]   [Full Text] [Related]  

  • 15. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.
    Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV
    Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease.
    Bayard M; Holt J; Boroughs E
    Am Fam Physician; 2006 Jun; 73(11):1961-8. PubMed ID: 16770927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interpretation of hypertransaminasemia].
    Othmani S; Bahri M; Bahri M
    Tunis Med; 2002 May; 80(5):236-44. PubMed ID: 12534025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis, clinical aspects and biochemistry of fatty liver].
    Müting D; Fischer R; Korn U; Reikowski J
    Dtsch Med Wochenschr; 1973 Apr; 98(14):733-7. PubMed ID: 4266619
    [No Abstract]   [Full Text] [Related]  

  • 19. Is NAFLD an incidentaloma?
    Tarantino G
    Gastroenterology; 2006 Mar; 130(3):1014-5. PubMed ID: 16530549
    [No Abstract]   [Full Text] [Related]  

  • 20. [Development of hepatic steatosis].
    Girard JD; Hofstetter JR
    Helv Med Acta Suppl; 1969; 49():158-66. PubMed ID: 5267565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.